Vitamins, Minerals, and Supplements CDMO Market Revenue Forecast 2026-2035
According to Shivani Zoting, who specializes in Nutraceuticals, Dietary Supplements, and Healthcare Contract Manufacturing, with 5+ years of experience in market research and industry analysis. My research indicates that the Vitamins, Minerals, and Supplements CDMO Market is set to grow from USD 52.84 billion in 2026 to USD 121.38 billion by 2035, driven by rising preventive healthcare awareness, personalized nutrition demand, and expanding nutraceutical brands. Manufacturing services, tablets, and dietary supplements currently represent the largest market segments, while gummies, chewables, and direct-to-consumer brands show strong growth potential. North America maintains market leadership, whereas Asia Pacific is emerging as the fastest-growing region. Competitive activity remains concentrated among established CDMOs such as Catalent, Lonza, Aenova Group, Sirio Pharma, Akums Drugs & Pharmaceuticals, NutraScience Labs, Robinson Pharma, Procaps Group, and Recipharm, which continue to expand capabilities through innovation, advanced formulation technologies, and strategic investments.
Last Updated : 25 June 2026
Category: Healthcare Services
Insight Code: 6882
Format: PDF / PPT / Excel